Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunogenicity, Vaccine”

4,710 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,710 results

Testing effectiveness (Phase 2)Study completedNCT02529930
What this trial is testing

An Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3)

Who this might be right for
High Grade Cervical Intraepithelial Neoplasia
Nykode Therapeutics ASA 34
Early research (Phase 1)Study completedNCT01335347
What this trial is testing

Safety Study of an Oral Vaccine to Prevent Avian Influenza

Who this might be right for
Avian InfluenzaBird Flu
Vaxart 54
Early research (Phase 1)Study completedNCT03961438
What this trial is testing

Amsterdam UMC Clinical Trial With a Native-like HIV-1 Envelope Vaccine

Who this might be right for
HIV-1-infection
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 24
Early research (Phase 1)Study completedNCT04830800
What this trial is testing

A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC (Phase 1)

Who this might be right for
COVID-19 DiseaseSARS PneumoniaPneumonia, Viral+1 more
Institute of Vaccines and Medical Biologicals, Vietnam 120
Post-approval studies (Phase 4)UnknownNCT05415345
What this trial is testing

Immunogenicity and Safety of Co-immunization With Cecolin and Hecolin

Who this might be right for
Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18Hepatitis E Virus Infection
Xiamen Innovax Biotech Co., Ltd 480
Large-scale testing (Phase 3)Study completedNCT03321968
What this trial is testing

Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults

Who this might be right for
Virus DiseasesRNA Virus InfectionsRespiratory Tract Infections+2 more
Medicago 1,202
Testing effectiveness (Phase 2)Study completedNCT04072497
What this trial is testing

A Clinical Study of a Zoster Vaccine in Healthy Adults >= 40 Years

Who this might be right for
Herpes Zoster
Shanghai Institute Of Biological Products 522
Testing effectiveness (Phase 2)Study completedNCT00506350
What this trial is testing

Evaluate Reactogenicity & Immunogenicity of an Influenza Pandemic Candidate Vaccine (GSK1562902A) in Primed Adults

Who this might be right for
Influenza
GlaxoSmithKline 350
Not applicableStudy completedNCT01641315
What this trial is testing

Immunogenicity Study of a Reduced (4-dose) Vaccine Schedule and Rabies Immunoglobulins

Who this might be right for
Rabies
Queen Saovabha Memorial Institute 75
Testing effectiveness (Phase 2)Study completedNCT00439335
What this trial is testing

Higher Dose Intradermal H5 Vaccine

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 227
Testing effectiveness (Phase 2)UnknownNCT05490108
What this trial is testing

Evaluation of Safety and Immunogenicity of the Recombinant ZR202-CoV and ZR202a-CoV Vaccines in Adults.

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
Shanghai Zerun Biotechnology Co.,Ltd 60
Early research (Phase 1)Study completedNCT01407497
What this trial is testing

Safety and Immunogenicity Study of a DNA Priming and MVA Boosting Strategy of HIV Vaccine

Who this might be right for
HIV Infections
Instituto Nacional de Saúde, Mozambique 25
Post-approval studies (Phase 4)Study completedNCT05398926
What this trial is testing

Immunogenicity and Safety of a Third Dose of COVID-19 Vaccine(Vero Cell), Inactivated in the Elderly

Who this might be right for
COVID-19
Sinovac Life Sciences Co., Ltd. 400
Early research (Phase 1)Study completedNCT02374385
What this trial is testing

Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine

Who this might be right for
Ebola Viruses
Dalhousie University 40
Early research (Phase 1)Study completedNCT00919178
What this trial is testing

Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue Virus

Who this might be right for
Dengue Shock SyndromeDengue Hemorrhagic Fever
National Institute of Allergy and Infectious Diseases (NIAID) 70
Early research (Phase 1)Study completedNCT00347555
What this trial is testing

Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly

Who this might be right for
Plasmodium Falciparum Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 80
Large-scale testing (Phase 3)Study completedNCT05549908
What this trial is testing

Vaccine Prevention of Rabies Adopts 4-shot Immunization Method

Who this might be right for
Rabies HumanAntibody Titer
Changchun Zhuoyi Biological Co., Ltd 1,800
Post-approval studies (Phase 4)Study completedNCT00258817
What this trial is testing

Phase IV Trial to Collect Safety Data and Sera in Healthy Children Given Fluzone Vaccine

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 30
Early research (Phase 1)Looking for participantsNCT07047989
What this trial is testing

NWRD09 for HPV-16 Related Cervical HSIL

Who this might be right for
High-grade Squamous Intraepithelial Lesion (HSIL)
Newish Biotech (Wuxi) Co., Ltd. 9
Early research (Phase 1)Active Not RecruitingNCT05945485
What this trial is testing

Evaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 50
Load More Results